Brazil to export vaccine against measles, rubella

Brazil will produce a combined vaccine against measles and rubella exclusively for export to poor countries, mainly in Africa, its health minister said Monday.

Alexandre Padilha said the aim was to produce 30 million doses by 2017 for sale at a price of 54 US cents each. Currently such vaccines are made only in India.

Padilha made the announcement at an event in Rio where he announced that the government was inking an investment deal with the US Bill & Melinda Gates foundation to develop the .

He said his ministry would invest $727 million in construction of a state-of-the pharmaceutical plant at the Bio-Manguinhos Institute, a government institution located in Rio.

"This plant will generate employment, revenue, know-how, research and technological innovation in this country," he added.

"The agreement which we are signing provides more investments and buying guarantees, which makes it possible to export at the lowest cost," he said.

The Gates Foundation is meanwhile allocating $1.1 million for the project.

Measles was eradicated in Brazil in 2000 and (or German measles) in 2009.

But the diseases remain endemic in some countries.

In 2011, 158,000 people died of around the world, most of them in , according to data from the World Health Organization.

Meanwhile Carlos Gadelha, the health ministry's science and technology secretary said Latin America's dominant economic power also hopes to make headway toward developing the pentavalent vaccine and a vaccine against dengue fever.

The pentavalent vaccine simultaneously provides protection against five life threatening diseases - Diphtheria, Pertussis, Tetanus, Hepatitis B and Hib (Haemophilus influenza type b).

add to favorites email to friend print save as pdf

Related Stories

Timing of first dose of measles vaccine questioned

Oct 21, 2013

(HealthDay)—Children who receive the first dose of a two-dose schedule of measles vaccine at 12 to 13 months compared with 15 months or later have a greater risk of developing measles, according to a study ...

Recommended for you

Seniors successfully withdraw from meds

Sep 19, 2014

Elderly people have proved receptive to being de-prescribed medications, as part of a trial aimed at assessing the feasibility of withdrawal of medications among older people.

Flu vaccine for expectant moms a top priority

Sep 18, 2014

Only about half of all pregnant women in the U.S. get a flu shot each season, leaving thousands of moms-to-be and their babies at increased risk of serious illness.

Experts want restrictions on testosterone drug use (Update)

Sep 17, 2014

Federal health experts said Wednesday there is little evidence that testosterone-boosting drugs are effective for treating common signs of aging in men and that their use should be narrowed to exclude millions of Americans ...

User comments